Predictive factors for premature birth and respiratory exacerbation in pregnancies of women with cystic fibrosis

J Pediatr (Rio J). 2022 Jan-Feb;98(1):33-38. doi: 10.1016/j.jped.2021.02.009. Epub 2021 Jun 8.

Abstract

Objective: In this present study, the authors evaluated the predictive factors for adverse maternal-fetal outcomes in pregnancies of women with cystic fibrosis (CF). Patients were followed up by a referral center for adults in southern Brazil.

Methods: This is a retrospective cohort study that used data from electronic medical records regarding pregnancies of women diagnosed with CF.

Results: The study included 39 pregnancies related to 20 different women. The main adverse outcomes were high prevalence rates of premature birth (38.5%) and maternal respiratory exacerbation (84.6%). Lower body mass index (BMI) values (< 20.8) and younger ages of CF diagnosis increased the risk of premature birth. The presence of methicillin-resistant and absence of methicillin-sensitive Staphylococcus aureus, as well as a younger age of diagnosis, increased the risk of maternal respiratory exacerbation during pregnancy.

Conclusions: Conception in women with CF is often associated with maternal and fetal complications. Continuous monitoring by a multidisciplinary team should emphasize appropriate nutritional status, investigation of bacterial colonization, and immediate attention to respiratory exacerbations.

Keywords: Cystic fibrosis; High-risk pregnancy; Obstetric complications; Pregnancy.

MeSH terms

  • Adult
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / epidemiology
  • Female
  • Humans
  • Nutritional Status
  • Pregnancy
  • Pregnancy Complications* / epidemiology
  • Pregnancy Outcome
  • Premature Birth* / epidemiology
  • Premature Birth* / etiology
  • Retrospective Studies